Eye Care in Russia

Euromonitor International, March 2012, Pages: 34

Slight economic growth started in 2010, which continued in 2011, resulting in unemployment rates decreasing to around the pre-crisis level. The spread of information on eye problems, and the growing availability of modern formats of pharmacies led to the growing penetration of eye care products.

The Eye Care in Russia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Allergy Eye Care, Standard Eye Care.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Eye Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

EYE CARE IN RUSSIA
Euromonitor International
March 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Eye Care by Category: Value 2006-2011
Table 2 Sales of Eye Care by Category: % Value Growth 2006-2011
Table 3 Standard Eye Care by Format: % Value Breakdown 2007-2011
Table 4 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
Table 5 Eye Care Company Shares by Value 2007-2011
Table 6 Eye Care Brand Shares by Value 2008-2011
Table 7 Forecast Sales of Eye Care by Category: Value 2011-2016
Table 8 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016
Sanofi-aventis Russia in Consumer Health (russia)
Strategic Direction
Key Facts
Summary 1 Sanofi-Aventis Russia: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Sanofi-Aventis Russia: Competitive Position 2011
Veropharm Oao in Consumer Health (russia)
Strategic Direction
Key Facts
Summary 3 Veropharm OAO: Key Facts
Summary 4 Veropharm OAO: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Veropharm OAO: Competitive Position 2011
Executive Summary
Optimistic Year Despite Negative Regulatory Settings
Basis for Future Development Under Construction
Higher-priced Products Regain Their Attractiveness
Changes in Pharmacy Retail Continue
Growth in Per Capita Consumption To Support Stable Market Development
Key Trends and Developments
Russian Government Puts Further Effort Into Reducing Dependence on Imports
Ban on OTC Drug Precursors
Pharmacy Retail Enters A New Stage of Development
Healthier Lifestyles Drive Sales of Vitamins and Dietary Supplements
Russia Fights Counterfeit Drugs
City Key Trends and Developments
Moscow
St Petersburg
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 10 Life Expectancy at Birth 2006-2011
Market Data
Table 11 Sales of Consumer Health by Category: Value 2006-2011
Table 12 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 13 Sales of Consumer Health by City: Value 2006-2011
Table 14 Sales of Consumer Health by City: % Value Growth 2006-2011
Table 15 Consumer Health Company Shares 2007-2011
Table 16 Consumer Health Brand Shares 2008-2011
Table 17 Penetration of Private Label by Category 2006-2011
Table 18 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 19 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 20 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 22 Forecast Sales of Consumer Health by City: Value 2011-2016
Table 23 Forecast Sales of Consumer Health by City: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Sources
Summary 6 Research Sources

Despite obstacles, sales continue to grow
OTC healthcare developed significantly in value sales in 2003. The introduction of VAT in 2002 and new certification regulations led to a general price rise for medicines, which was felt throughout 2003. Rising unit prices was one of the important factors that kept OTC sales increasing at a fast rate throughout the year. In addition, large outbreaks of flu early and later in the year stimulated specific remedies, such as cough remedies and analgesics.

Companies Mentioned Include:
- Nizhfarm OAO
- Verofarm ZAO
- Akrikhin OAO
- Pfizer Inc
- Krka Pharma OOO
- GlaxoSmithKline Plc
- Aventis Pharma (Russia)
- Bausch & Lomb European Pharmaceuticals
- Tatchimfarmpreparati KPNFO
- Alcon Pharmaceuticals Ltd
- Schering-Plough Central East AG
- Galena as/ Norton Healthcare Ltd
- Pliva dd
- Janssen Pharmaceutica NV
- Warszawa ZF Polfa

Customers who bought this item also bought

• Russia Generics and Biosimilars
• Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth
• Nutraceuticals - Global Strategic Business Report
• The 2010 Biopesticides Markets In Asia, Australasia And Russia (Volume 4 of a 6 Volume Series)
• Taking Advantage of Protein-Based Therapy Opportunities
• Probiotics - Global Strategic Business Report
• Global Biopharmaceutical Market Report & Forecast (2012-2017)
• Biophotonics - Global Strategic Business Report
• Global Flow Cytometry Market
• Coronary Stents - Global Strategic Business Report